Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Leiomyosarcoma × Biopsy × Clear all

Status

Sponsor Class

NIH 2 NETWORK 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Uterine Cervical Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Dysplasia 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Skin Neoplasms 1 Sarcoma, Endometrial Stromal 1 Precancerous Conditions 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Leiomyosarcoma 1 Leiomyoma 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Genital Diseases 1 Female Urogenital Diseases and Pregnancy Complications 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

Dacarbazine 5 Doxorubicin 4 Trabectedin 3 belinostat 2 PTC596 2 soblidotin 1 rucaparib 1 ridaforolimus 1 reolysin 1 pembrolizumab 1 pazopanib 1 olaratumab 1 futibatinib 1 cixutumumab 1 cemiplimab 1 anlotinib 1 Tablets 1 TTI-621 1 Rosuvastatin Calcium 1 PM 01183 1 Midazolam 1 Imatinib Mesylate 1 Fluorouracil 1 Erlotinib Hydrochloride 1 Docetaxel 1 Digoxin 1 Dexamethasone 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04214457 2021-09-05

MYOSARC

Igenomix

Leiomyoma, Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡